Investor · Cambridge, MA

John Ripple

Open John in the network graph →

Filings

9

SEC Form D

Connections

32

co-filers

Capital

$48.1M

across filings

Active

Nov 2017

to Aug 2022

Most-connected co-filers (32)

L. P. Gage · Cambridge, MA6 shared Evan D. Burtton · George Town, Grand Cayman, Cayman Islands3 shared Christian B. Sowul · SAN FRANCISCO, CA3 shared Martin Taylor · San Francisco, CA3 shared Anders Hove · NEW YORK, NY3 shared Eric I. Aguiar · Natick, MA3 shared Jennifer Gallagher · LONG BEACH, CA3 shared David Sherman · New York, NY3 shared David T. Nasaw · NEW YORK, NY3 shared Michael Steinmetz · Cambridge, MA3 shared T. R. Burke · New York, NY3 shared Scott Brabant · Old Saybrook, CT3 shared (a limited liability company) MedOp Acquisition, LLC · Old Saybrook, CT3 shared Gail Wasserman · Cambridge, MA3 shared John W. Vander Vort · BOSTON, MA3 shared Jeenjoo J. Kang · Cambridge, MA2 shared H. J. Magee · Cambridge, MA2 shared David Goeddel · San Francisco, CA2 shared Michael Blady · Vancouver, British Columbia, Canada1 shared Martin Lehr · Philadelphia, PA1 shared Pradip Majumder · Arlington, MA1 shared Shawn Titcomb · Lauderdale by the Sea, FL1 shared Sohang Chatterjee · Arlington, MA1 shared Clayton M. Olson · VANCOUVER, British Columbia, Canada1 shared

Recent filings (9)

Praesidia Biotherapeutics, Inc.Aug 2022 · 13 co-filers$10.0M Praesidia Biotherapeutics, Inc.Aug 2022 · 13 co-filers$10.0M Exonics Therapeutics, Inc.Nov 2018 · 11 co-filers$42.0M Exonics Therapeutics, Inc.Nov 2018 · 11 co-filers$42.0M Exonics Therapeutics, Inc.Nov 2017 · 7 co-filers$42.0M Exonics Therapeutics, Inc.Nov 2017 · 7 co-filers$42.0M Virdante Pharmaceuticals, Inc.Oct 2011 · 11 co-filers$47.8M Virdante Pharmaceuticals, Inc.Oct 2010 · 11 co-filers$47.8M MEDOP SERVICES LLCOct 2010 · 5 co-filers$8.0M MEDOP SERVICES LLCMay 2010 · 5 co-filers$2.5M Virdante Pharmaceuticals, Inc.Oct 2009 · 11 co-filers$47.8M MEDOP SERVICES LLCOct 2009 · 5 co-filers$1.5M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See John in the interactive graph →